Correction to: Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic.

Brown, Brandon; Weiss, Jamie L; Kolodny, Scott; Meng, Xiangyi; Williams, Ian M; Osborne, John A

Brown, Brandon; Weiss, Jamie L; Kolodny, Scott; Meng, Xiangyi; Williams, Ian M; Osborne, John A.

Afiliación

Brown B; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936, USA.
Weiss JL; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936, USA.
Kolodny S; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936, USA.
Meng X; Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ, 07936, USA.
Williams IM; Oxford PharmaGenesis, Tubney Warren Barn, Tubney, Oxford, OX13 5QJ, UK.
Osborne JA; State of the Heart Cardiology, Plaza 1, Medical Pkwy. N Suite 103, Dallas, TX, 75234, USA. josborne@sothcardiology.com.

BMC Neurol ; 19(1): 336, 2019 12 21.

Article en En | MEDLINE | ID: mdl-31864306

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: BMC Neurol Asunto de la revista: NEUROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google